Britain approves Pfizer-BioNTech shot for younger children

Britain's medicines regulator on Wednesday approved use of the COVID-19 vaccine from partners Pfizer and BioNTech for children aged 5 to 11 years, after the watchdog found the shot was safe and effective.

The country's vaccines committee advised that children in the age group who were in a clinical risk group should be offered the shot.

The children will receive two 10-microgram doses of the Pfizer-BioNTech vaccine - a third of the adult dose - with an interval of eight weeks between the first and second doses, the Joint Committee on Vaccination and Immunisation said.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy